Hillsdale Investment Management Inc. Axogen, Inc. Transaction History

Hillsdale Investment Management Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$8.5 - $10.38 $519,605 - $634,529	-61,130 Reduced 99.56%	270 $2,000
Q1 2023 May 10, 2023	SELL	$7.53 - $10.95 $22,590 - $32,850	-3,000 Reduced 4.66%	61,400 $580,000
Q4 2022 Feb 13, 2023	BUY	$9.44 - $13.09 $607,936 - $842,996	64,400 New	64,400 $642,000

163

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $534M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.